ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 174 filers reported holding ACORDA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 2.08 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $0 | -100.0% | 290 | -29.3% | 0.00% | – |
| Q4 2019 | $1,000 | -85.7% | 410 | -83.7% | 0.00% | – |
| Q3 2019 | $7,000 | +40.0% | 2,514 | +251.1% | 0.00% | – |
| Q2 2019 | $5,000 | -68.8% | 716 | -41.0% | 0.00% | – |
| Q1 2019 | $16,000 | -11.1% | 1,214 | +3.2% | 0.00% | – |
| Q4 2018 | $18,000 | -48.6% | 1,176 | -34.8% | 0.00% | – |
| Q3 2018 | $35,000 | -31.4% | 1,803 | +1.6% | 0.00% | – |
| Q2 2018 | $51,000 | +34.2% | 1,774 | +11.4% | 0.00% | – |
| Q1 2018 | $38,000 | +81.0% | 1,593 | +62.1% | 0.00% | – |
| Q4 2017 | $21,000 | -40.0% | 983 | -32.6% | 0.00% | – |
| Q3 2017 | $35,000 | +66.7% | 1,458 | +38.2% | 0.00% | – |
| Q2 2017 | $21,000 | 0.0% | 1,055 | +2.6% | 0.00% | – |
| Q1 2017 | $21,000 | +31.2% | 1,028 | +19.3% | 0.00% | – |
| Q4 2016 | $16,000 | -83.3% | 862 | -81.1% | 0.00% | – |
| Q3 2016 | $96,000 | -51.0% | 4,553 | -41.0% | 0.00% | – |
| Q2 2016 | $196,000 | +429.7% | 7,712 | +440.4% | 0.00% | – |
| Q1 2016 | $37,000 | -22.9% | 1,427 | +26.4% | 0.00% | – |
| Q4 2015 | $48,000 | +108.7% | 1,129 | +26.3% | 0.00% | – |
| Q3 2015 | $23,000 | -36.1% | 894 | -17.5% | 0.00% | – |
| Q2 2015 | $36,000 | +28.6% | 1,084 | +30.4% | 0.00% | – |
| Q1 2015 | $28,000 | -73.1% | 831 | -67.4% | 0.00% | – |
| Q4 2014 | $104,000 | +2500.0% | 2,547 | +1859.2% | 0.00% | – |
| Q3 2014 | $4,000 | 0.0% | 130 | 0.0% | 0.00% | – |
| Q2 2014 | $4,000 | -82.6% | 130 | -78.9% | 0.00% | – |
| Q1 2014 | $23,000 | +21.1% | 616 | -5.1% | 0.00% | – |
| Q4 2013 | $19,000 | -20.8% | 649 | -6.5% | 0.00% | – |
| Q3 2013 | $24,000 | +4.3% | 694 | +1.5% | 0.00% | – |
| Q2 2013 | $23,000 | – | 684 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 428,000 | $8,046,000 | 1.90% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,532,067 | $85,203,000 | 1.61% |
| DLD Asset Management, LP | 247,300 | $4,656,000 | 1.52% |
| Broadfin Capital, LLC | 644,153 | $12,110,000 | 1.34% |
| Perceptive Advisors | 720,000 | $13,536,000 | 0.96% |
| DLD Asset Management, LP | 135,493 | $2,547,000 | 0.83% |
| Malaga Cove Capital, LLC | 51,013 | $971,000 | 0.64% |
| Baker Brothers Advisors | 3,301,791 | $62,074,000 | 0.61% |
| Worth Venture Partners, LLC | 29,300 | $551,000 | 0.59% |
| Spark Investment Management LLC | 327,900 | $6,164,000 | 0.51% |